Surgical alternatives to mechanical support

Abstract

Get full access to this article

View all access options for this article.

References

Ho KK , Anderson KM , Kannel WB , Grossman W , Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects . Circulation 1993; 88: 107-115 .

Phillips SJ , Whisnant JP , O’Fallon WM , Frye RL. Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota . Mayo Clin Proc 1990; 65: 344-359 .

Swedberg K and Kjekshus J. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) . Am J Cardiol 1988; 62: 60-66A .

Anon. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial . Lancet 1999; 353: 9-13 .

Anon . Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) . Lancet 1999; 353: 2001-2007 .

Pitt B , Zannad F , Remme WJ et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators . New Engl J Med 1999; 341: 709-717 .

Sutton GC. Epidemiologic aspects of heart failure . Am Heart J 1990; 120: 1538-1540 .

Hosenpud JD , Bennett LE , Keck BM , Fiol B , Boucek MM , Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: sixteenth official report - 1999 . J Heart Lung Transplant 1999; 18: 611-626 .

United Kingdom Transplant Support Service Authority . Transplant update, United Kingdom Transplant Support Service Authority. Stoke Gifford, Bristol , 1999.

10.

Kottke TE , Pesch DG , Frye RL , McGoon DC , Warnes CA , Kurland LT. The potential contribution of cardiac replacement to the control of cardiovascular diseases. A population-based estimate . Arch Surg 1990; 125: 1148-1151 .

11.

Macris MP. Permanent mechanical replacement of the left ventricle . Cardiol Clin 1995; 13: 111-120 .

12.

Portner PM , Oyer PE , Pennington DG et al. Implantable electrical left ventricular assist system: bridge to transplantation and the future . Ann Thorac Surg 1989; 47: 142-150 .

13.

Frazier OH , Rose EA , Macmanus Q et al. Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device . Ann Thorac Surg 1992; 53: 1080-1090 .

14.

McCarthy PM. HeartMate implantable left ventricular assist device: bridge to transplantation and future applications . Ann Thorac Surg 1995; 59: S46-S51 .

15.

Rose EA , Moskowitz AJ , Packer M et al. The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure . Ann Thorac Surg 1999; 67: 723-730 .

16.

Parameshwar J , Wallwork J. Left ventricular assist devices: current status and future applications . Int J Cardiol 1997; 1: S23-S27 .

17.

Barnard CN. The operation. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town . S Afr Med J 1967; 41: 1271-1274 .

18.

International Society of Heart-Lung Transplantation. Database. http://www.ighlt.org/registry.html/

19.

United Kingdom Transplant Support Service Authority . Cardiothoracic organ transplant audit, 1985-1995. Stoke Gifford, Bristol: United Kingdom Transplant Support Service Authority , 1996: 54-54.

20.

Bourge RC , Naftel DC , Costanzo-Nordin MR et al. Pretransplantation risk factors for death after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group . J Heart Lung Transplant 1993; 12: 549-562 .

21.

Miller LW , Naftel DC , Bourge RC et al. Infection after heart transplantation: a multiinstitutional study. Cardiac Transplant Research Database Group . J Heart Lung Transplant 1994; 13: 381-392 ; discussion 393.

22.

The Royal College of Surgeons of England . The Report of the Working Party to Review Organ Transplantation, January 1999. London: Royal College of Surgeons of England , 1999: 8-8.

23.

Kobashigawa JA. Advances in immunosuppression for heart transplantation . Adv Cardiac Surg 1998; 10: 155-174 .

24.

Wallwork J. Current status of xenotransplantation . Int J Cardiol 1997; 1: S37-S38 .

25.

Artrip JH , Itescu S , Minanov OP , Kwiatkowski PA , Michler RE. Cardiac xenotransplantation . Curr Opin Cardiol 1997; 12: 172-178 .

26.

Williams N. Pig-human transplants barred for now . Science 1997; 275: 473-473 .

27.

Weiss RA. Xenotransplantation . Br Med J 1998; 317: 931-934 .

28.

Weiss RA. Xenografts and retroviruses . Science 1999; 285: 1221-1222 .

29.

United Kingdom Xenotransplantation Interim Regulatory Authority. Draft report of the infection surveillance steering group of the UKXIRA. http://doh.gov.uk/surveil.htm

30.

Williams N. Paving the way for British xenotransplants . Science 1998; 281: 767-767 .

31.

Batista RJ , Santos JL , Takeshita N , Bocchino L , Lima PN , Cunha MA. Partial left ventriculectomy to improve left ventricular function in end-stage heart disease . J Cardiac Surg 1996; 11: 96-97 ; discussion 98.

32.

Batista RJ , Verde J , Nery P et al. Partial left ventriculectomy to treat end-stage heart disease . Ann Thorac Surg 1997; 64: 634-638 .

33.

Kresh J , Wechsler A. Heart reduction surgery can reconstitute the residual stress strain in the left ventricle . J Thorac Cardiovasc Surg 1998; 116: 1084-1086 .

34.

Gorcsan J, III , Feldman AM , Kormos RL , Mandarino WA , Demetris AJ , Batista RJ. Heterogeneous immediate effects of partial left ventriculectomy on cardiac performance . Circulation 1998; 97: 839-842 .

35.

Starling RC , Young JB. Surgical therapy for dilated cardiomyopathy . Cardiol Clin 1998; 16: 727-737 .

36.

Bolling SF , Deeb GM , Brunsting LA , Bach DS. Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy . J Thorac Cardiovasc Surg 1995; 109: 676-682 ; discussion 682-83.

37.

Bolling SF , Pagani FD , Deeb GM , Bach DS. Intermediate-term outcome of mitral reconstruction in cardiomyopathy . J Thorac Cardiovasc Surg 1998; 115: 381-386 ; discussion 387-88.

38.

Chachques JC , Grandjean PA , Carpentier A. Latissimus dorsi dynamic cardiomyoplasty . Ann Thorac Surg 1989; 47: 600-604 .

39.

Bocchi EA , Bellotti G , Moreira LF et al. Mid-term results of heart transplantation, cardiomyoplasty, and medical treatment of refractory heart failure caused by idiopathic dilated cardiomyopathy . J Heart Lung Transplant 1996; 15: 736-745 .

40.

Furnary AP , Jessup FM , Moreira LP. Multicenter trial of dynamic cardiomyoplasty for chronic heart failure. The American Cardiomyoplasty Group . J Am Coll Cardiol 1996; 28: 1175-1180 .

41.

Furnary AP , Chachques JC , Moreira LF et al. Long-term outcome, survival analysis, and risk stratification of dynamic cardiomyoplasty . J Thorac Cardiovasc Surg 1996; 112: 1640-1649 ; discussion 1649-50.

42.

Moreira LF , Stolf NA , Braile DM , Jatene AD. Dynamic cardiomyoplasty in South America . Ann Thorac Surg 1996; 61: 408-412 .

43.

Grandjean PA , Austin L , Chan S , Terpstra B , Bourgeois IM. Dynamic cardiomyoplasty: clinical follow-up results . J Cardiac Surg 1991; 6: 80-88 .

44.

Lorusso R , Zogno M , La Canna G et al. Dynamic cardiomyoplasty as an effective therapy for dilated cardiomyopathy . J Cardiac Surg 1993; 8: 177-183 .

45.

Magovern JA , Park SE , Cmolik BL , Trumble DR , Christlieb IY , Magovern GJ, Sr. Early effects of right latissimus dorsi cardiomyoplasty on left ventricular function . Circulation 1993; 88: II298-II303 .

46.

Moreira LF , Bocchi EA , Bacal F , Stolf NA , Bellotti G , Jatene AD. Present trends in clinical experience with dynamic cardiomyoplasty . Int J Artif Organs 1995; 19: 211-216 .

47.

Grandjean P , Acker M , Madoff R , Williams NS , Woloszko J , Kantor C. Dynamic myoplasty: surgical transfer and stimulation of skeletal muscle for functional substitution or enhancement [Review] . J Rehab Res Dev 1996; 33: 133-144 .

48.

Melvin DB , Glos DL , Abiog MC , Litsky AS. Coupling of skeletal muscle to a prosthesis for circulatory support . ASAIO J 1997; 43: M434-M441 .

49.

Teerlink JR , Goldhaber SZ , Pfeffer MA. An overview of contemporary etiologies of congestive heart failure . Am Heart J 1991; 121: 1852-1853 .

50.

Rahimtoola SH. The hibernating myocardium . Am Heart J 1989; 117: 211-221 .

51.

Cohn JN , Rector TS. Prognosis of congestive heart failure and predictors of mortality . Am J Cardiol 1988; 62: 25-30A .

52.

Townend JN , Pagano D , Allen SM et al. Results of surgical revascularization in ischaemic heart failure without angina . Eur J Cardiothorac Surg 1995; 9: 507-513 ; discussion 513-14.

53.

Kaul S.

There may be more to revascularisation than meets the eye!

Circulation 1995; 92: 2790-2793 .

54.

Pagano D , Townend JN , Littler WA , Horton R , Camici PG , Bonser RS. Coronary artery bypass surgery as treatment for ischemic heart failure: the predictive value of viability assessment with quantitative positron emission tomography for symptomatic and functional outcome . J Thorac Cardiovasc Surg 1998; 115: 791-799 .

55.

Pagley PR , Beller GA , Watson DD , Gimple LW , Ragosta M. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability . Circulation 1997; 96: 793-800 .

56.

Afridi I , Grayburn PA , Panza JA , Oh JK , Zoghbi WA , Marwick TH. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction . J Am Coll Cardiol 1998; 32: 921-926 .

57.

Zaret BL , Wackers FJ. Nuclear cardiology (1) . New Engl J Med 1993; 329: 775-783 .

58.

Pagano D , Bonser RS , Townend JN , Ordoubadi F , Lorenzoni R , Camici PG. Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure . Heart 1998; 79: 281-288 .

59.

Gerber BL , Vanoverschelde JL , Bol A et al. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation . Circulation 1996; 94: 651-659 .

60.

Alderman EL , Fisher LD , Litwin P et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS) . Circulation 1983; 68: 785-795 .

61.

Pigott JD , Kouchoukos NT , Oberman A , Cutter GR. Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function . J Am Coll Cardiol 1985; 5: 1036-1045 .

62.

Bounous EP , Mark DB , Pollock BG et al. Surgical survival benefits for coronary disease patients with left ventricular dysfunction . Circulation 1988; 78: I151-I157 .

63.

Pagano D , Lewis ME , Townend J , Davies P , Camici PG , Bonser RS. Coronary revascularisation for postischaemic heart failure: how myocardial viabilty affects survival . Heart 1999; 82: 684-688 .

64.

vom Dahl J , Eitzman DT , al-Aouar ZR et al. Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization . Circulation 1994; 90: 2356-2366 .

65.

Gunning MG , Chua TP , Harrington D et al. Hibernating myocardium: clinical and functional response to revascularisation . Eur J Cardiothorac Surg 1997; 11: 1105-1112 .

66.

Di Carli MF , Asgarzadie F , Schelbert HR et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy . Circulation 1995; 92: 3436-3444 .

67.

Dreyfus GD , Duboc D , Blasco A et al. Myocardial viability assessment in ischemic cardiomyopathy: benefits of coronary revascularization . Ann Thorac Surg 1994; 57: 1402-1407 ; discussion 1407-408.

68.

al-Mohammad A , Mahy IR , Norton MY et al. Prevalence of hibernating myocardium in patients with severely impaired ischaemic left ventricles . Heart 1998; 80: 559-564 .

69.

Lewis SJ , Sawada SG , Ryan T , Segar DS , Armstrong WF , Feigenbaum H. Segmental wall motion abnormalities in the absence of clinically documented myocardial infarction: clinical significance and evidence of hibernating myocardium . Am Heart J 1991; 121: 1088-1094 .

70.

Angelini GD , Pryn S , Mehta D et al. Left-ventricular-volume reduction for end-stage heart failure [letter; see comments] . Lancet 1997; 350: 489-489 .

71.

McCarthy JF , McCarthy PM , Starling RC et al. Partial left ventriculectomy and mitral valve repair for end-stage congestive heart failure . Eur J Cardiothorac Surg 1998; 13: 337-343 .

72.

Moreira LF , Stolf NA , Higuchi ML , Bocchi EA , Bacal F , Jatene AD.

What is the role of partial left ventriculectomy in the treatment of idiopathic dilated cardiomyopathy?

Abstracts of the 13th Annual meeting of the EACTS 005. http://www.eacts.org//abstract/816

73.

Popovic Z , Miric M , Gradinac S et al. Effects of partial left ventriculectomy on left ventricular performance in patients with nonischemic dilated cardiomyopathy . J Am Coll Cardiol 1998; 32: 1801-1808 .

74.

Etoch SW , Koenig SC , Laureano MA , Cerrito P , Gray LA , Dowling RD. Results after partial left ventriculectomy versus heart transplantation for idiopathic cardiomyopathy . J Thorac Cardiovasc Surg 1999; 117: 952-959 .